An Epidemiological Study to Investigate the Characteristics of RSV Infection in Adult Hematopoietic Cell Transplant Recipients or Hematological Malignancies Patients in Tianjin HI (Hematology Institute)

Recruiting

• Conditions: RSV Infection

• Registration Number: NCT06490549
• Lead Sponsor: Institute of Hematology & Blood Diseases Hospital, China

Brief Summary

This primary objective of this study is to describe the incidence of RSV infection in adult hematopoietic cell transplant recipients OR hematological malignancies patients in Tianjin HI.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-11-30
• Status Verified: 2023-12
• Study First Submitted: 2023-12-06
• Study First Submitted QC: 2024-06-28
• Last Update Submitted: 2024-06-28
• Study First Posted: 2024-07-08
• Last Update Posted: 2024-07-08
• Primary Completion: 2025-06-20
• Study Completion: 2025-06-20

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• 1. Aged ≥ 18 years old. 2) Receiving hematopoietic stem cell transplantation; OR being diagnosed with hematological malignancies (including but not limited to leukemia, lymphoma, and multiple myeloma) and receiving chemotherapy.

  2. New onset of respiratory symptoms; OR exacerbation of existing chronic respiratory symptoms (such as previously diagnosed chronic runny nose, seasonal allergies, chronic lung disease, etc.).

  3. Willing to sign an informed consent form, able to understand and willing to follow the study protocol.

Exclusion Criteria

• Unwillingness to sign an informed consent form.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
the incidence of RSV infection in adult hematopoietic stem cell transplantation (HCT) recipients OR hematological malignancies (HM) patients presenting the study site	1 year	infection incidence
the Incidence of RSV infection in adult hematopoietic stem cell transplantation (HCT) recipients OR hematological malignancies (HM) patients presenting the hospital	1 year	infection incidence

Secondary Outcome Measures

Name	Time	Method
Clinical outcome and relevant risk factor of RSV infection	1 year	Clinical outcome and relevant risk factor of RSV infection
Virological characteristics of RSV infection from D1 through D28, D42 or even longer	1 year	Clinical outcome and relevant risk factor of RSV infection
the clinical characteristics of RSV infection	1 year	symptoms description and scoring of RSV infection

Trial Locations

Locations (1)

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences; 🇨🇳 Tianjin, China